The Latest Breaking News from Ventas

Ventas stock just appeared on John Rowland’s favorite stock screener, but he’s looking for a confluence of indicators to find trade ideas.

Ventas has outpaced the broader market over the past year, and Wall Street analysts maintain a highly optimistic outlook on the stock’s prospects.

Ventas will release its first-quarter earnings next week, and analysts anticipate a single-digit bottom-line growth.

Due to Ventas’s outperformance relative to the Dow Jones over the past year, analysts are bullish about the stock’s prospects.

Healthcare REITs are delivering healthy dividends while capitalizing on the growing demand for medical facilities. In this article, we’ll explore three healthcare REITs, Welltower (WELL), Ventas (VTR), and National Health Investors (NHI) that could be added to your watchlist. Read on.

Ventas has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

As the healthcare real estate market flourishes, fueled by demographic transformations and cutting-edge advancements in healthcare delivery, fundamentally robust stalwarts like Welltower (WELL), Ventas (VTR), and Omega Healthcare Investors (OHI) shine as premier investment opportunities. Dive deeper to discover how these REITs are shaping the future while delivering healthy returns.

Ventas has underperformed the Nasdaq over the past year, but analysts are moderately optimistic about the stock’s prospects.

Throughout the last three months, 5 analysts have evaluated Ventas (NYSE:VTR), offering a diverse set of opinions from bullish to bearish.